234 related articles for article (PubMed ID: 34402706)
1. Folic acid-modified ROS-responsive nanoparticles encapsulating luteolin for targeted breast cancer treatment.
Wang Y; Wang Q; Feng W; Yuan Q; Qi X; Chen S; Yao P; Dai Q; Xia P; Zhang D; Sun F
Drug Deliv; 2021 Dec; 28(1):1695-1708. PubMed ID: 34402706
[TBL] [Abstract][Full Text] [Related]
2. Targeted delivery of antibiotics to the infected pulmonary tissues using ROS-responsive nanoparticles.
Wang Y; Yuan Q; Feng W; Pu W; Ding J; Zhang H; Li X; Yang B; Dai Q; Cheng L; Wang J; Sun F; Zhang D
J Nanobiotechnology; 2019 Oct; 17(1):103. PubMed ID: 31581948
[TBL] [Abstract][Full Text] [Related]
3. Luteolin-Loaded Nanoparticles for the Treatment of Melanoma.
Fu QT; Zhong XQ; Chen MY; Gu JY; Zhao J; Yu DH; Tan F
Int J Nanomedicine; 2023; 18():2053-2068. PubMed ID: 37101838
[TBL] [Abstract][Full Text] [Related]
4. Reactive oxygen species-responsive dexamethasone-loaded nanoparticles for targeted treatment of rheumatoid arthritis via suppressing the iRhom2/TNF-α/BAFF signaling pathway.
Ni R; Song G; Fu X; Song R; Li L; Pu W; Gao J; Hu J; Liu Q; He F; Zhang D; Huang G
Biomaterials; 2020 Feb; 232():119730. PubMed ID: 31918224
[TBL] [Abstract][Full Text] [Related]
5. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance.
Zhong P; Chen X; Guo R; Chen X; Chen Z; Wei C; Li Y; Wang W; Zhou Y; Qin L
Mol Pharm; 2020 Apr; 17(4):1114-1126. PubMed ID: 32176509
[TBL] [Abstract][Full Text] [Related]
6. Roxithromycin and rhEGF Co-loaded Reactive Oxygen Species Responsive Nanoparticles for Accelerating Wound Healing.
Ding J; Chen D; Hu J; Zhang D; Gou Y; Wu Y
Curr Drug Deliv; 2024; 21(5):753-762. PubMed ID: 37183469
[TBL] [Abstract][Full Text] [Related]
7. Folic acid-modified ginsenoside Rg5-loaded bovine serum albumin nanoparticles for targeted cancer therapy in vitro and in vivo.
Dong Y; Fu R; Yang J; Ma P; Liang L; Mi Y; Fan D
Int J Nanomedicine; 2019; 14():6971-6988. PubMed ID: 31507319
[TBL] [Abstract][Full Text] [Related]
8. Docetaxel-loaded pH/ROS dual-responsive nanoparticles with self-supplied ROS for inhibiting metastasis and enhancing immunotherapy of breast cancer.
Wang Y; Wang Q; Wang X; Yao P; Dai Q; Qi X; Yang M; Zhang X; Huang R; Yang J; Wang Q; Xia P; Zhang D; Sun F
J Nanobiotechnology; 2023 Aug; 21(1):286. PubMed ID: 37608285
[TBL] [Abstract][Full Text] [Related]
9. Delivery luteolin with folacin-modified nanoparticle for glioma therapy.
Wu C; Xu Q; Chen X; Liu J
Int J Nanomedicine; 2019; 14():7515-7531. PubMed ID: 31571861
[TBL] [Abstract][Full Text] [Related]
10. Design, In Silico Modelling, and Functionality Theory of Novel Folate Receptor Targeted Rutin Encapsulated Folic Acid Conjugated Keratin Nanoparticles for Effective Cancer Treatment.
Kunjiappan S; Panneerselvam T; Govindaraj S; Parasuraman P; Baskararaj S; Sankaranarayanan M; Arunachalam S; Babkiewicz E; Jeyakumar A; Lakshmanan M
Anticancer Agents Med Chem; 2019; 19(16):1966-1982. PubMed ID: 31267878
[TBL] [Abstract][Full Text] [Related]
11. Targeted poly (L-γ-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells.
Tavassolian F; Kamalinia G; Rouhani H; Amini M; Ostad SN; Khoshayand MR; Atyabi F; Tehrani MR; Dinarvand R
Int J Pharm; 2014 Jun; 467(1-2):123-38. PubMed ID: 24680951
[TBL] [Abstract][Full Text] [Related]
12. Vitamin E TPGS modified liposomes enhance cellular uptake and targeted delivery of luteolin: An in vivo/in vitro evaluation.
Li J; Cheng X; Chen Y; He W; Ni L; Xiong P; Wei M
Int J Pharm; 2016 Oct; 512(1):262-272. PubMed ID: 27545748
[TBL] [Abstract][Full Text] [Related]
13. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery.
Zhang C; Zhao L; Dong Y; Zhang X; Lin J; Chen Z
Eur J Pharm Biopharm; 2010 Sep; 76(1):10-6. PubMed ID: 20472060
[TBL] [Abstract][Full Text] [Related]
14. Folic acid functionalized starch encapsulated green synthesized copper oxide nanoparticles for targeted drug delivery in breast cancer therapy.
Mariadoss AVA; Saravanakumar K; Sathiyaseelan A; Venkatachalam K; Wang MH
Int J Biol Macromol; 2020 Dec; 164():2073-2084. PubMed ID: 32784027
[TBL] [Abstract][Full Text] [Related]
15. Folate-Chitosan Nanoparticles Loaded with Ursolic Acid Confer Anti-Breast Cancer Activities in vitro and in vivo.
Jin H; Pi J; Yang F; Jiang J; Wang X; Bai H; Shao M; Huang L; Zhu H; Yang P; Li L; Li T; Cai J; Chen ZW
Sci Rep; 2016 Jul; 6():30782. PubMed ID: 27469490
[TBL] [Abstract][Full Text] [Related]
16. Oral Delivery of Gambogenic Acid by Functional Polydopamine Nanoparticles for Targeted Tumor Therapy.
Wang B; Yuan T; Zha L; Liu Y; Chen W; Zhang C; Bao Y; Dong Q
Mol Pharm; 2021 Mar; 18(3):1470-1479. PubMed ID: 33586444
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic-loaded reactive oxygen species-responsive nanomedicine for effective management of chronic bacterial prostatitis.
Zheng J; Hu R; Yang Y; Wang Y; Wang Q; Xu S; Yao P; Liu Z; Zhou J; Yang J; Bao Y; Zhang D; Shen W; Zhou Z
Acta Biomater; 2022 Apr; 143():471-486. PubMed ID: 35259516
[TBL] [Abstract][Full Text] [Related]
18. Oxi-Redox Selective Breast Cancer Treatment: An In Vitro Study of Theranostic In-Based Oxide Nanoparticles for Controlled Generation or Prevention of Oxidative Stress.
Hsu NS; Tehei M; Hossain MS; Rosenfeld A; Shiddiky MJA; Sluyter R; Dou SX; Yamauchi Y; Konstantinov K
ACS Appl Mater Interfaces; 2021 Jan; 13(2):2204-2217. PubMed ID: 33399455
[TBL] [Abstract][Full Text] [Related]
19. Salvianolic acid B protects against myocardial damage caused by nanocarrier TiO
Ding L; Li J; Huang R; Liu Z; Li C; Yao S; Wang J; Qi D; Li N; Pi J
Int J Nanomedicine; 2016; 11():5709-5727. PubMed ID: 27843313
[TBL] [Abstract][Full Text] [Related]
20. Curcumin-loaded redox-responsive mesoporous silica nanoparticles for targeted breast cancer therapy.
Li N; Wang Z; Zhang Y; Zhang K; Xie J; Liu Y; Li W; Feng N
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):921-935. PubMed ID: 29790797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
